Covid-19: After UAE, Kuwait approves new treatment
For treating mild to moderate coronavirus cases.
Kuwait's Ministry of Health has approved GSK and Vir Biotechnology's Sotrovimab as a treatment for coronavirus, state news KUNA reported on Wednesday.
Kuwait is the second country in the Middle East to approve the use of the antibody treatment for mild to moderate Covid-19 cases, after the UAE.
Kuwait also announced on Wednesday a $40 million donation to COVAX, the international program designed to help supply developing countries with vaccines against the disease, KUNA said.
Dr. Abdullah Al Badr, the assistant undersecretary for medicines and nutrition supervision, told Kuna the drug is used for such cases among adults and children aged 12 and above, Kuna reported.
He added that the medicine is also used for persons of 65 years of age and above, but not for hospitalised patients who need oxygen due to Covid-19 infection.
Clinical studies have shown that this medicine has lowered hospital admissions and deaths by 85 per cent. It prevents the virus from entering human cells.
(with inputs from Reuters)
Modi and US Vice President Kamala Harris discuss efforts to improve... READ MORE
The government council approved the extension to combat Covid and... READ MORE
This is for the first time Abu Dhabi is permitting mixing of Covid-19 ... READ MORE
UK PM has warned that it could derail plans for lockdown restrictions ... READ MORE
More than 53.3 million PCR tests have been conducted across the... READ MORE
VPN use is illegal when it comes to accessing or downloading calling... READ MORE
You’d need the pass to gain entry to most public places... READ MORE
Any establishment that does not comply with the decision will be... READ MORE